Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational Burden.

Clinical chemistry(2022)

Cited 6|Views12
No score
Abstract
The TMB500 assay is an accurate and reliable ctDNA assay for many clinical purposes. It may be useful for guiding the treatment of cancers with diverse genomic profiles, estimating TMB in immune therapy, and disease monitoring.
More
Translated text
Key words
circulating tumor DNA,liquid biopsy,next-generation sequencing,predictive biomarker,targeted gene panel,tumor mutational burden
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined